Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 9, Issue 6
March 25 2025
In Progress
Issue Cover

CLINICAL GUIDELINES

American Society of Hematology living guidelines on use of anticoagulation for thromboprophylaxis for patients with COVID-19: executive summary
Deborah M. Siegal,Eric K. Tseng,Holger J. Schünemann,Pantep Angchaisuksiri,Adam Cuker,Kathryn Dane,Maria T. DeSancho,David Diuguid,Daniel O. Griffin,Frederikus A. Klok,Alfred Ian Lee,Ignacio Neumann,Ashok Pai,Marc Righini,Kristen M. Sanfilippo,Deirdra R. Terrell,Elie A. Akl,Reyad Al Jabiri,Yazan Al Jabiri,Angela M. Barbara,Antonio Bognanni,Imad Bou Akl,Mary Boulos,Romina Brignardello-Petersen,Matthew Chan,Rana Charide,Luis E. Colunga-Lozano,Karin Dearness,Andrea J. Darzi,Heba Hussein,Samer G. Karam,Philipp Kolb,Razan Mansour,Gian Paolo Morgano,Rami Z. Morsi,Giovanna Muti-Schünemann,Menatalla K. Nadim,Atefeh Noori,Binu A. Philip,Thomas Piggott,Yuan Qiu,Yetiani Roldan Benitez,Finn Schünemann,Adrienne Stevens,Karla Solo,Wojtek Wiercioch,Reem A. Mustafa,Robby Nieuwlaat
View Articletitled, American Society of Hematology living guidelines on use of anticoagulation for thromboprophylaxis for patients with COVID-19: executive summary
Supplemental data

RESEARCH LETTER

Combination therapies of porcupine inhibition with ruxolitinib, ibrutinib, or belumosudil in murine sclerodermatous GVHD
Xuezhi Hong,Yanhua Xiao,Liyan Xu,Lichong Shen,Ranjana Neelagar,Veda Devakumar,Thuong Trinh-Minh,Minrui Liang,Aleix Rius Rigau,Yun Zhang,Yi-Nan Li,Clara Dees,Andrea-Hermina Györfi,Daniel Wolff,Wolfgang Herr,Georg Schett,Jörg H. W. Distler,Alexandru-Emil Matei
View Articletitled, Combination therapies of porcupine inhibition with ruxolitinib, ibrutinib, or belumosudil in murine sclerodermatous GVHD
Supplemental data
Differential effects of C5 inhibition, C3 inhibition, and alternative pathway inhibition on bacterial killing in vitro
Mendy ter Avest,Zenno de Boer,Saskia M. C. Langemeijer,Nicole C. A. J. van de Kar,Marien I. de Jonge,Rob ter Heine,Jeroen D. Langereis
View Articletitled, Differential effects of C5 inhibition, C3 inhibition, and alternative pathway inhibition on bacterial killing in vitro
Supplemental data
G3BP1::CSF1R: a new and actionable gene fusion in acute megakaryoblastic leukemia
Xi Luo,Chi-Keung Cheng,Hoi-Yun Chan,Kam-Tong Leung,Chi-Kong Li,Nellie Yuk-Fei Chung,Herbert Augustus Pitts,Ke Tian,Yuet-Fong Kam,Margaret H.L. Ng
View Articletitled, G3BP1::CSF1R: a new and actionable gene fusion in acute megakaryoblastic leukemia
Supplemental data
The A-HIPI prediction model in advanced-stage Hodgkin lymphoma: identification of risk groups and creation of an online tool
Clinical Trials & Observations
Matthew J. Maurer,Susan K. Parsons,Jenica N. Upshaw,Angie Mae Rodday,Raphael Mwangi,Sára Rossetti,Jonathan W. Friedberg,Andrea Gallamini,Massimo Federico,Eliza Hawkes,David Hodgson,Peter Johnson,Brian K. Link,Eric Mou,Kerry J. Savage,Pier Luigi Zinzani,Andrew M. Evens
View Articletitled, The A-HIPI prediction model in advanced-stage Hodgkin lymphoma: identification of risk groups and creation of an online tool
Characteristics of infections after BCMA-directed CAR T-cell therapy for multiple myeloma: a real-world analysis
Tim Richardson,Daniel Schütte,Guido Kobbe,Ben-Niklas Baermann,Tobias A. W. Holderried,Friederike Schmitz,Martina Crysandt,Michael Hallek,Christoph Scheid,Udo Holtick,Oliver A. Cornely,Jannik Stemler,Sibylle C. Mellinghoff
View Articletitled, Characteristics of infections after BCMA-directed CAR T-cell therapy for multiple myeloma: a real-world analysis

Lymphoid Neoplasia

Subclonal TP53 and KRAS variants combined with poor treatment response identify ultrahigh-risk pediatric patients with T-ALL
Tamara Kempter,Paulina Richter-Pechańska,Katarzyna Michel,Tobias Rausch,Büşra Erarslan-Uysal,Cornelia Eckert,Martin Zimmermann,Martin Stanulla,Martin Schrappe,Gunnar Cario,Stefan Köhrer,Andishe Attarbaschi,Jan O. Korbel,Joachim B. Kunz,Andreas E. Kulozik
View Articletitled, Subclonal <em>TP53</em> and <em>KRAS</em> variants combined with poor treatment response identify ultrahigh-risk pediatric patients with T-ALL
Supplemental data
Pediatric relapsed/refractory ALK-positive anaplastic large cell lymphoma treatment and outcomes in the targeted-drug era
Lianna J. Marks,Victor Ritter,Jennifer E. Agrusa,Kala Y. Kamdar,Julie Rivers,Rebecca Gardner,Matthew J. Ehrhardt,Kaitlin J. Devine,Charles A. Phillips,Anne Reilly,Keith August,Joanna Weinstein,Prakash Satwani,Christopher J. Forlenza,Christine Moore Smith,Chelsee Greer,Zeinab Afify,Carol H. Lin,Jennifer A. Belsky,Hilda Ding,David Hoogstra,Keri Toner,Michael P. Link,Liora M. Schultz,Eric J. Lowe,Catherine Aftandilian
View Articletitled, Pediatric relapsed/refractory ALK-positive anaplastic large cell lymphoma treatment and outcomes in the targeted-drug era
Supplemental data

Plasma Cell Disorders

Health care systems as determinants of outcomes in multiple myeloma: final results from the Latin American MYLACRE study
Clinical Trials & Observations
Vania Hungria,Rafael Gaiolla,Kenny Galvez,Guillermina Remaggi,Natalia Schutz,Rosane Bittencourt,Angelo Maiolino,Guillermo Quintero-Vega,Maria Silvana Cugliari,Walter Moises Tobias Braga,Carolina Colaco Villarim,Edvan Crusoe,Alicia Ines Enrico,Gaston Caiero,Jandey Bigonha,Fernanda Lemos Moura,Jair Figueroa,Claudia Lucia Sossa Melo,Milton Lombana,Huiling Pei,Mariana Fernandez,Jaqueline Saes,Damila Cristina Trufelli
View Articletitled, Health care systems as determinants of outcomes in multiple myeloma: final results from the Latin American MYLACRE study

MYELOID NEOPLASIA

Relationship between additional mutations at diagnosis and treatment response in patients with essential thrombocythemia
Carole Mosnier,Sarah Bellal,Laurane Cottin,Françoise Boyer,Sandrine Lemoine,Amélie Bachelot,Joris Argentin,Bertille Pawlicki,Marie-Christine Copin,Rébecca Jouanneau-Courville,Anaïs Malinge,Jérémie Riou,Mathilde Hunault-Berger,Valérie Ugo,Corentin Orvain,Damien Luque Paz
View Articletitled, Relationship between additional mutations at diagnosis and treatment response in patients with essential thrombocythemia
Supplemental data
Double mutant DNMT3A AML: a unique subtype experiencing increased DNA damage and poor prognosis
Emma L. Boertjes,Sanne Massaar,Annelieke Zeilemaker,Jolinda Konijnenburg,Melissa Rijken,François G. Kavelaars,Tim Grob,Jurjen Versluis,Bob Löwenberg,Peter J. M. Valk,Mathijs A. Sanders
View Articletitled, Double mutant <em>DNMT3A</em> AML: a unique subtype experiencing increased DNA damage and poor prognosis
Supplemental data
Anxiety and depression in patients with histiocytic neoplasms and their associated clinical features
Anne S. Reiner,Yesne Alici,Denise D. Correa,Dana Bossert,Allison M. Sigler,Deanna Fournier,Kathleen Brewer,Gaurav Goyal,Thomas M. Atkinson,Priya Marathe,Jun J. Mao,Katherine S. Panageas,Eli L. Diamond
View Articletitled, Anxiety and depression in patients with histiocytic neoplasms and their associated clinical features
Supplemental data

THROMBOSIS AND HEMOSTASIS

Cost-effectiveness of Voncento prophylaxis vs on-demand treatment in von Willebrand disease in the United Kingdom
Michele Wilson,Giancarlo Castaman,Will Thomas,Carolyn Millar,Ginés Escolar,Wolfgang Miesbach,Cheryl McDade,Radovan Tomic,Songkai Yan
View Articletitled, Cost-effectiveness of Voncento prophylaxis vs on-demand treatment in von Willebrand disease in the United Kingdom
Imbalanced VWF-ADAMTS13 axis contributes to the detrimental impact of a preceding respiratory tract infection on stroke
Rakesh B. Patel,Abhishek B. Jha,Aditi Jain,Abhishek K. Verma,Saurabh Saini,Joshua Muia,Prajwal Gurung,Stanley Perlman,Ivan Budnik,Anil K. Chauhan
View Articletitled, Imbalanced VWF-ADAMTS13 axis contributes to the detrimental impact of a preceding respiratory tract infection on stroke
Supplemental data

CLINICAL TRIALS AND OBSERVATIONS

High pulmonary hypertension risk by echocardiogram shortens survival in polycythemia vera
Clinical Trials & Observations
Alexander J. Gazda,Di Pan,Katie Erdos,Ghaith Abu-Zeinah,Alexandra Racanelli,Evelyn M. Horn,Joseph M. Scandura
View Articletitled, High pulmonary hypertension risk by echocardiogram shortens survival in polycythemia vera
Supplemental data

Inside Blood Advances

VWF-ADAMTS13 imbalance bridges infection to stroke
Jing-fei Dong,Cha Han
View Articletitled, VWF-ADAMTS13 imbalance bridges infection to stroke
Predicting risk in Hodgkin lymphoma for research and clinical practice
Ruohui Chen,Leo I. Gordon
View Articletitled, Predicting risk in Hodgkin lymphoma for research and clinical practice

ADVANCES SNAPSHOT

Imetelstat: drugging telomerase in transfusion-dependent low- and intermediate-1–risk MDS
Clinical Trials & Observations
Joseph Cannova,Rafael Madero-Marroquin,Olatoyosi Odenike
View Articletitled, Imetelstat: drugging telomerase in transfusion-dependent low- and intermediate-1–risk MDS
All Issues

Advertisement intended for health care professionals

VWF-ADAMTS13 imbalance bridges infection to stroke
Predicting risk in Hodgkin lymphoma for research and clinical practice
Differential effects of C5 inhibition, C3 inhibition, and alternative pathway inhibition on bacterial killing in vitro
Relationship between additional mutations at diagnosis and treatment response in patients with essential thrombocythemia
Pediatric relapsed/refractory ALK-positive anaplastic large cell lymphoma treatment and outcomes in the targeted-drug era

Advertisement intended for health care professionals

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals